Fatal leukemia in interleukin-15 transgenic mice

被引:36
作者
Fehniger, TA
Suzuki, K
VanDeusen, JB
Cooper, MA
Freud, AG
Caligiuri, MA
机构
[1] Ohio State Univ, Dept Internal Med, Div Hematol Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Comphrehens Canc Ctr, Columbus, OH 43210 USA
[4] Gunma Univ, Sch Med, Dept Urol, Gunma, Japan
关键词
D O I
10.1006/bcmd.2001.0379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of inflammation in the early genesis of certain malignancies has recently been appreciated. Interleukin (IL)-15, a proinflammatory cytokine and growth factor, is required for lymphocyte homeostasis. Intriguingly, the expression of IL-15 protein is tightly controlled by multiple posttranscriptional mechanisms, suggesting that inappropriate expression of IL-15 may be detrimental to the host. We recently engineered a transgenic mouse in which the normal posttranscriptional control of IL-15 is eliminated, thereby overexpressing the murine IL-15 protein. IL-15 transgenic mice have early expansions in NK and CD8(+) T lymphocytes and later develop fatal lymphocytic leukemia with a T-NK phenotype. This article recapitulates the phenotype of these IL-15 transgenic mice and discusses the utility of this model as a tool to further our understanding of leukemogenesis. (C) 2001 Academic Press.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 37 条
  • [1] Bamford RN, 1998, J IMMUNOL, V160, P4418
  • [2] Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation
    Bamford, RN
    Battiata, AP
    Burton, JD
    Sharma, H
    Waldmann, TA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) : 2897 - 2902
  • [3] THE INTERLEUKIN (IL)-2 RECEPTOR-BETA CHAIN IS SHARED BY IL-2 AND A CYTOKINE, PROVISIONALLY DESIGNATED IL-T, THAT STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS
    BAMFORD, RN
    GRANT, AJ
    BURTON, JD
    PETERS, C
    KURYS, G
    GOLDMAN, CK
    BRENNAN, J
    ROESSLER, E
    WALDMANN, TA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4940 - 4944
  • [4] REGULATED EXPRESSION OF A MURINE CLASS-I GENE IN TRANSGENIC MICE
    BIEBERICH, C
    SCANGOS, G
    TANAKA, K
    JAY, G
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (04) : 1339 - 1342
  • [5] Interleukin-15 protects from lethal apoptosis in vivo
    BulfonePaus, S
    Ungureanu, D
    Pohl, T
    Lindner, G
    Paus, R
    Ruckert, R
    Krause, H
    Kunzendorf, U
    [J]. NATURE MEDICINE, 1997, 3 (10) : 1124 - 1128
  • [6] CALIGIURI MA, 2000, CANC PRINCIPLES PRAC
  • [7] Potential role for interleukin-15 in the regulation of human natural killer cell survival
    Carson, WE
    Fehniger, TA
    Haldar, S
    Eckhert, K
    Lindemann, MJ
    Lai, CF
    Croce, CM
    Baumann, H
    Caligiuri, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) : 937 - 943
  • [8] INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR
    CARSON, WE
    GIRI, JG
    LINDEMANN, MJ
    LINETT, ML
    AHDIEH, M
    PAXTON, R
    ANDERSON, D
    EISENMANN, J
    GRABSTEIN, K
    CALIGIURI, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1395 - 1403
  • [9] At the crossroads of inflammation and tumorigenesis
    Cordon-Cardo, C
    Prives, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) : 1367 - 1370
  • [10] Interleukin-1 polymorphisms associated with increased risk of gastric cancer
    El-Omar, EM
    Carrington, M
    Chow, WH
    McColl, KEL
    Bream, JH
    Young, HA
    Herrera, J
    Lissowska, J
    Yuan, CC
    Rothman, N
    Lanyon, G
    Martin, M
    Fraumeni, JF
    Rabkin, CS
    [J]. NATURE, 2000, 404 (6776) : 398 - 402